橫幅
News
25
2025.06
Tulex Pharmaceuticals, the U.S. subsidiary,announced that TLX-047, an anti-inflammatory drug,has received FDA approval notification.
Tulex Pharmaceuticals,announced that TLX-047, an anti-inflammatory drug,has received FDA approval notification.
more
01
2025.05
代⼦公司美國Tulex Pharmaceuticals公告,共同開發新藥(505(b)(2)）液態⼝服治療尿崩症藥品,已向美國FDA 提出新劑型新藥查驗登記申請(NDA)
more
17
2024.12
本公司及子公司Tulex Pharmaceuticals Inc.共同與合作夥伴簽訂TLX-050神經系統用藥之合作開發合約，新增第三方合作夥伴
more
27
2024.09
HH-001沙庫巴曲纈沙坦鈉片(悅欣妥)大陸市場擴展狀況
more
18
2024.03
孫公司江蘇華瀚醫藥科技有限公司HH-001沙庫巴曲纈沙坦鈉片(悅心妥)重磅上市
more